GlassScriptPhysician profile
Nachiket Apte
NPI 1821355322
$44,152.69
in general payments reported to CMS, 2019-2025
14 companies · $3,719 in 2025
The $3,719 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $1,019 · 2021: $889 · 2022: $3,634 · 2023: $1,005 · 2024: $985 · 2025: $3,719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,597 · Food and Beverage: $2,041 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,597.16 |
| Food and Beverage | $2,041.13 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $27,793.30 | 2019-2020 | |
| Abbott Laboratories | $6,070.18 | 2019-2025 | Na, Aveir, Ensite |
| Boston Scientific Corporation | $3,887.16 | 2019-2025 | General - Therapies, S-Icd System Magnet, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $2,818.63 | 2021-2025 | Selectsecure, Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan |
| Biotronik INC. | $1,768.67 | 2020-2022 | |
| Philips North America LLC | $654.28 | 2023-2025 | (Bs2) Lm Undivided, (Am5) Lead Management, Lm Undivided |
| Cvrx, INC. | $494.01 | 2021-2022 | |
| Medical Device Business Services, INC. | $217.88 | 2019 | |
| Abiomed | $186.08 | 2021 | |
| Amgen INC. | $140.46 | 2025 | Tepezza |
| Impulse Dynamics (USA) INC. | $42.09 | 2021 | |
| Ethicon US, LLC | $31.80 | 2025 | Stratafix |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.41 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nachiket Apte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.